Radiation oncology firm Sirtex Medical has debuted Siros, a delivery system for its yttrium-90 (Y-90) microspheres.
The system is designed to deliver the company's SIR-Spheres Y-90 resin microspheres to patients undergoing radioembolization therapy for liver cancer. It uses visually controlled administration to help physicians quickly and precisely deliver the microspheres, the company noted.
The SIROS Y-90 microspheres deliveries system. Image courtesy of Sirtex.Siros also features a three-step setup, peel-and-place tubing set, and locking cover to secure the microspheres during delivery. It also utilized needleless D-Vials that suspend the SIR-Spheres into a vortex for more even distribution.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
